Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2015, Article ID 518167, 7 pages
http://dx.doi.org/10.1155/2015/518167
Research Article

Prevalence of Plasmid-Mediated Quinolone Resistance Determinants and OqxAB Efflux Pumps among Extended-Spectrum -Lactamase Producing Klebsiella pneumoniae Isolated from Patients with Nosocomial Urinary Tract Infection in Tehran, Iran

1Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1985717443, Iran
2Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 1985717443, Iran
3Department of Medical Laboratory Sciences, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin 1651135779, Iran
4Department of Medical Mycology, Pasteur Institute of Iran, Tehran 1316943551, Iran

Received 3 June 2015; Accepted 21 July 2015

Academic Editor: Joaquim Ruiz

Copyright © 2015 Mehdi Goudarzi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W.-C. Ko, D. L. Paterson, A. J. Sagnimeni et al., “Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns,” Emerging Infectious Diseases, vol. 8, no. 2, pp. 160–166, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Saladin, V. T. B. Cao, T. Lambert et al., “Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals,” FEMS Microbiology Letters, vol. 209, no. 2, pp. 161–168, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. M. M. Feizabadi, S. Delfani, N. Raji et al., “Distribution of bla TEM, bla SHV, bla CTX-M genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran,” Microbial Drug Resistance, vol. 16, no. 1, pp. 49–53, 2010. View at Google Scholar
  4. J. Strahilevitz, G. A. Jacoby, D. C. Hooper, and A. Robicsek, “Plasmid-mediated quinolone resistance: a multifaceted threat,” Clinical Microbiology Reviews, vol. 22, no. 4, pp. 664–689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Martínez-Martínez, A. Pascual, and G. A. Jacoby, “Quinolone resistance from a transferable plasmid,” The Lancet, vol. 351, no. 9105, pp. 797–799, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Robicsek, J. Strahilevitz, G. A. Jacoby et al., “Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase,” Nature Medicine, vol. 12, no. 1, pp. 83–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. L. H. Hansen, L. B. Jensen, H. I. Sørensen, and S. J. Sørensen, “Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria,” Journal of Antimicrobial Chemotherapy, vol. 60, no. 1, pp. 145–147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Yuan, X. Xu, Q. Guo et al., “Prevalence of the oqxAB gene complex in Klebsiella pneumoniae and Escherichia coli clinical isolates,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 7, Article ID dks086, pp. 1655–1659, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Rodríguez-Martínez, P. D. de Alba, A. Briales et al., “Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-β-lactamase-producing Klebsiella pneumoniae,” Journal of Antimicrobial Chemotherapy, vol. 68, no. 1, pp. 68–73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Rodríguez-Martínez, A. Pascual, I. García, and L. Martínez-Martínez, “Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type β-lactamase,” Journal of Antimicrobial Chemotherapy, vol. 52, no. 4, pp. 703–706, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. C. H. Park, A. Robicsek, G. A. Jacoby, D. Sahm, and D. C. Hooper, “Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 11, pp. 3953–3955, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Cattoir, L. Poirel, V. Rotimi, C.-J. Soussy, and P. Nordmann, “Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates,” Journal of Antimicrobial Chemotherapy, vol. 60, no. 2, pp. 394–397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Chen, W. Zhang, W. Pan et al., “Prevalence of qnr, aac(6′)-Ib-cr, qepA, and oqxAB in Escherichia coli isolates from humans, animals, and the environment,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 6, pp. 3423–3427, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Robicsek, J. Strahilevitz, D. F. Sahm, G. A. Jacoby, and D. C. Hooper, “qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 8, pp. 2872–2874, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Luce, “Koneman's color atlas and textbook of diagnostic microbiology, 6th edition,” Plastic & Reconstructive Surgery, vol. 125, no. 1, pp. 414–415, 2010. View at Publisher · View at Google Scholar
  16. Clinical Laboratory Standards Institute, “Performance standards for antimicrobial disc susceptibility tests, 22th international supplement,” Tech. Rep. M100-S22, CLSI, Wayne, Pa, USA, 2012, vol. 32, no. 3, pp. 50–60, 2012. View at Google Scholar
  17. S. Lee, Y.-J. Park, M. Kim et al., “Prevalence of Ambler class A and D β-lactamases among clinical isolates ofPseudomonas aeruginosa in Korea,” Journal of Antimicrobial Chemotherapy, vol. 56, no. 1, pp. 122–127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Shukla, R. Tiwari, and M. Agrawal, “Prevalence of extended spectrum β-lactamasee producing Klebsiella pneumoniae in a tertiary care hospital,” Indian Journal of Medical Microbiology, vol. 22, no. 2, pp. 87–91, 2004. View at Google Scholar · View at Scopus
  19. M. Goudarzi, S. S. Seyedjavadi, H. Goudarzi et al., “Characterization of coagulase-negative staphylococci isolated from hospitalized patients in Tehran, Iran,” Journal of Paramedical Sciences, vol. 5, no. 2, pp. 44–50, 2014. View at Google Scholar
  20. E. Lautenbach, B. L. Strom, W. B. Bilker, J. B. Patel, P. H. Edelstein, and N. O. Fishman, “Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae,” Clinical Infectious Diseases, vol. 33, no. 8, pp. 1288–1294, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. P. L. Winokur, R. Canton, J.-M. Casellas, and N. Legakis, “Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region,” Clinical Infectious Diseases, vol. 32, supplement 2, pp. S94–S103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Shanthi and U. Sekar, “Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes,” Journal of Association of Physicians of India, vol. 58, pp. 41–44, 2010. View at Google Scholar · View at Scopus
  23. A. Kaftandzieva, E. Trajkovska-Dokic, and N. Panovski, “Prevalence and molecular characterization of extended spectrum beta-lactamases (ESBLs) producing Escherichia coli and Klebsiella pneumoniae,” Prilozi, vol. 32, no. 2, pp. 129–141, 2011. View at Google Scholar
  24. E. D. V. Romero, T. P. Padilla, A. H. Hernández et al., “Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum β-lactamases,” Diagnostic Microbiology and Infectious Disease, vol. 59, no. 4, pp. 433–437, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. B. O. Akanbi, B. D. Ojonuba, and R. Njoku, “Detection of extended spectrum β-lactamase producing Klebsiella pneumoniae and Escherichia coli in two hospitals in the Federal Capital Territory, Abuja, Nigeria,” Open Journal of Medical Microbiology, vol. 3, no. 4, pp. 207–212, 2013. View at Publisher · View at Google Scholar
  26. S. Hosoglu, S. Gundes, F. Kolayli et al., “Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals,” Indian Journal of Medical Microbiology, vol. 25, no. 4, pp. 346–350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. H. M. Al-Agamy, A. M. Shibl, and A. F. Tawfik, “Prevalence and molecular characterization of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia,” Annals of Saudi Medicine, vol. 29, no. 4, pp. 253–257, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Sarojamma and V. Ramakrishna, “Prevalence of ESBL-producing Klebsiella pneumoniae isolates in tertiary care hospital,” ISRN Microbiology, vol. 2011, Article ID 318348, 5 pages, 2011. View at Publisher · View at Google Scholar
  29. Z. Xiong, D. Zhu, Y. Zhang, and F. Wang, “Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates,” Zhonghua Yi Xue Za Zhi, vol. 82, no. 21, pp. 1476–1479, 2002. View at Google Scholar · View at Scopus
  30. H. Goossens and M. S. Group, “MYSTIC program: summary of European data from 1997 to 2000,” Diagnostic Microbiology and Infectious Disease, vol. 41, no. 4, pp. 183–189, 2001. View at Google Scholar
  31. Y. Yu, S. Ji, Y. Chen et al., “Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in China,” Journal of Infection, vol. 54, no. 1, pp. 53–57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Šeputiene, M. Linkevičius, A. Bogdaite et al., “Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from hospitals in Lithuania,” Journal of Medical Microbiology, vol. 59, no. 10, pp. 1263–1265, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Nordmann and L. Poirel, “Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae,” Journal of Antimicrobial Chemotherapy, vol. 56, no. 3, pp. 463–469, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Pasom, A. Chanawong, A. Lulitanond, C. Wilailuckana, S. Kenprom, and P. Puang-Ngern, “Plasmid-mediated quinolone resistance genes, aac(6′)-Ib-cr, qnrS, qnrB, and qnrA, in urinary isolates of Escherichia coli and Klebsiella pneumoniae at a teaching hospital, Thailand,” Japanese Journal of Infectious Diseases, vol. 66, no. 5, pp. 428–432, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Briales, J. M. Rodríguez-Martínez, C. Velasco et al., “Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6′)-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain,” International Journal of Antimicrobial Agents, vol. 39, no. 5, pp. 431–434, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. H. S. Jeong, I. K. Bae, J. H. Shin et al., “Prevalence of plasmid-mediated quinolone resistance and its association with extended-spectrum beta-lactamase and AmpC beta-lactamase in Enterobacteriaceae,” The Korean Journal of Laboratory Medicine, vol. 31, no. 4, pp. 257–264, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Yang, H. Chen, Q. Yang, M. Chen, and H. Wang, “High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6′)-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 12, pp. 4268–4273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. A. S. S. Anuar, M. Y. M. Yusof, and S. T. Tay, “Prevalence of plasmid-mediated qnr determinants and gyrase alteration in Klebsiella pneumoniae isolated from a university teaching hospital in Malaysia,” European Review for Medical and Pharmacological Sciences, vol. 17, no. 13, pp. 1744–1747, 2013. View at Google Scholar · View at Scopus
  39. M. Wang, D. F. Sahm, G. A. Jacoby, and D. C. Hooper, “Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 4, pp. 1295–1299, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. J. W. P. Teo, K. Y. Ng, and R. T. P. Lin, “Detection and genetic characterisation of qnrB in hospital isolates of Klebsiella pneumoniae in Singapore,” International Journal of Antimicrobial Agents, vol. 33, no. 2, pp. 177–180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. L. A. R. Minarini, L. Poirel, V. Cattoir, A. L. C. Darini, and P. Nordmann, “Plasmid-mediated quinolone resistance determinants among enterobacterial isolates from outpatients in Brazil,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 3, pp. 474–478, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. W. M. Hassan, A. Hashim, and R. A. A. Domany, “Plasmid mediated quinolone resistance determinants qnr, aac(6′)-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt,” Indian Journal of Medical Microbiology, vol. 30, no. 4, pp. 442–447, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. G. A. Jacoby, N. Chow, and K. B. Waites, “Prevalence of plasmid-mediated quinolone resistance,” Antimicrobial Agents and Chemotherapy, vol. 47, no. 2, pp. 559–562, 2003. View at Publisher · View at Google Scholar · View at Scopus